WallStSmart

CubeSmart (CUBE)vsSabra Healthcare REIT Inc (SBRA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CubeSmart generates 45% more annual revenue ($1.13B vs $775.76M). CUBE leads profitability with a 29.6% profit margin vs 20.1%. SBRA appears more attractively valued with a PEG of 5.28. SBRA earns a higher WallStSmart Score of 57/100 (C).

CUBE

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 8.0Value: 6.0Quality: 3.0
Piotroski: 3/9Altman Z: 0.57

SBRA

Buy

57

out of 100

Grade: C

Growth: 5.3Profit: 6.5Value: 5.3Quality: 5.3
Piotroski: 5/9Altman Z: 0.46
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CUBEUndervalued (+33.0%)

Margin of Safety

+33.0%

Fair Value

$57.58

Current Price

$40.48

$17.10 discount

UndervaluedFair: $57.58Overvalued
SBRAUndervalued (+84.7%)

Margin of Safety

+84.7%

Fair Value

$127.86

Current Price

$20.35

$107.51 discount

UndervaluedFair: $127.86Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CUBE2 strengths · Avg: 9.5/10
Operating MarginProfitability
39.5%10/10

Strong operational efficiency at 39.5%

Profit MarginProfitability
29.6%9/10

Keeps 30 of every $100 in revenue as profit

SBRA4 strengths · Avg: 8.3/10
Profit MarginProfitability
20.1%9/10

Keeps 20 of every $100 in revenue as profit

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

Revenue GrowthGrowth
15.8%8/10

15.8% revenue growth

Areas to Watch

CUBE4 concerns · Avg: 3.0/10
P/E RatioValuation
27.1x4/10

Moderate valuation

Debt/EquityHealth
1.263/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
5.332/10

Expensive relative to growth rate

SBRA4 concerns · Avg: 2.8/10
P/E RatioValuation
31.8x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

PEG RatioValuation
5.282/10

Expensive relative to growth rate

EPS GrowthGrowth
-44.7%2/10

Earnings declined 44.7%

Comparative Analysis Report

WallStSmart Research

Bull Case : CUBE

The strongest argument for CUBE centers on Operating Margin, Profit Margin. Profitability is solid with margins at 29.6% and operating margin at 39.5%.

Bull Case : SBRA

The strongest argument for SBRA centers on Profit Margin, Price/Book, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 23.7%. Revenue growth of 15.8% demonstrates continued momentum.

Bear Case : CUBE

The primary concerns for CUBE are P/E Ratio, Debt/Equity, Piotroski F-Score.

Bear Case : SBRA

The primary concerns for SBRA are P/E Ratio, Return on Equity, PEG Ratio.

Key Dynamics to Monitor

CUBE profiles as a mature stock while SBRA is a growth play — different risk/reward profiles.

CUBE carries more volatility with a beta of 1.13 — expect wider price swings.

SBRA is growing revenue faster at 15.8% — sustainability is the question.

CUBE generates stronger free cash flow (122M), providing more financial flexibility.

Bottom Line

SBRA scores higher overall (57/100 vs 51/100), backed by strong 20.1% margins and 15.8% revenue growth. CUBE offers better value entry with a 33.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CubeSmart

REAL ESTATE · REIT - INDUSTRIAL · USA

CubeSmart is a self-managed and self-managed real estate investment trust.

Visit Website →

Sabra Healthcare REIT Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?

Want to dig deeper into these stocks?